UnitedHealth Group Yönetim

Yönetim kriter kontrolleri 3/4

UnitedHealth Group CEO'su Andrew Witty, Feb2021 tarihinde atandı, in görev süresi 4.25 yıldır. in toplam yıllık tazminatı $ 26.34M olup, şirket hissesi ve opsiyonları dahil olmak üzere 5.7% maaş ve 94.3% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.012% ine doğrudan sahiptir ve bu hisseler CLP 39.77B değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4.2 yıl ve 6.8 yıldır.

Anahtar bilgiler

Andrew Witty

İcra Kurulu Başkanı

US$26.3m

Toplam tazminat

CEO maaş yüzdesi	5.69%
CEO görev süresi	4.3yrs
CEO sahipliği	0.01%
Yönetim ortalama görev süresi	4.2yrs
Yönetim Kurulu ortalama görev süresi	6.8yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Andrew Witty'un ücretlendirmesi UnitedHealth Group'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Mar 31 2025	n/a	n/a	US$22b
Dec 31 2024	US$26m	US$2m	US$14b
Sep 30 2024	n/a	n/a	US$14b
Jun 30 2024	n/a	n/a	US$14b
Mar 31 2024	n/a	n/a	US$15b
Dec 31 2023	US$24m	US$2m	US$22b
Sep 30 2023	n/a	n/a	US$22b
Jun 30 2023	n/a	n/a	US$21b
Mar 31 2023	n/a	n/a	US$21b
Dec 31 2022	US$21m	US$2m	US$20b
Sep 30 2022	n/a	n/a	US$19b
Jun 30 2022	n/a	n/a	US$18b
Mar 31 2022	n/a	n/a	US$17b
Dec 31 2021	US$18m	US$1m	US$17b
Sep 30 2021	n/a	n/a	US$15b
Jun 30 2021	n/a	n/a	US$15b
Mar 31 2021	n/a	n/a	US$17b
Dec 31 2020	US$13m	US$419k	US$15b
Sep 30 2020	n/a	n/a	US$17b
Jun 30 2020	n/a	n/a	US$17b
Mar 31 2020	n/a	n/a	US$14b
Dec 31 2019	US$17m	US$1m	US$14b
Sep 30 2019	n/a	n/a	US$13b
Jun 30 2019	n/a	n/a	US$13b
Mar 31 2019	n/a	n/a	US$13b
Dec 31 2018	US$22m	US$613k	US$12b

Tazminat ve Piyasa: Andrew 'nin toplam tazminatı ($USD 26.34M ), CL pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 5.61M ).

Tazminat ve Kazançlar: Andrew 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Andrew Witty (59 yo)

4.3yrs

Görev süresi

US$26,339,215

Tazminat

Sir Andrew Philip Witty has been the Chief Executive Officer and Non-Independent Director of UnitedHealth Group Incorporated since February 3, 2021 and served as its Group President from November 2019 unti...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Andrew Witty	CEO & Non-Independent Director	4.3yrs	US$26.34m	0.012% CLP 39.8b
John Rex	President & CFO	8.9yrs	US$18.73m	0.021% CLP 68.9b
Christopher Zaetta	Executive VP	less than a year	US$6.87m	0.0011% CLP 3.7b
Erin L. McSweeney	Executive VP & Chief People Officer	3.2yrs	US$6.27m	0.0012% CLP 4.0b
Heather Cianfrocco	EVP of Governance	no data	US$11.45m	0.0025% CLP 8.0b
Thomas Roos	Senior VP & Chief Accounting Officer	9.8yrs	Veri yok	0.0032% CLP 10.5b
Sandeep Dadlani	Executive VP and Chief Digital & Technology Officer	2.7yrs	Veri yok	Veri yok
Zachary Sopcak	Senior Vice President of Capital Markets Communications & Investor Relations	3.2yrs	Veri yok	Veri yok
Jennifer Smoter	Senior VP & Chief Communications Officer	4.2yrs	Veri yok	Veri yok
Terry Clark	Executive VP & Chief Marketing Officer	11.3yrs	Veri yok	Veri yok
Richard Migliori	Executive Vice President & Senior Advisor	12.3yrs	Veri yok	Veri yok
Daniel Schumacher	Chief Strategy & Growth Officer	no data	Veri yok	Veri yok

4.2yrs

Ortalama Görev Süresi

55.5yo

Ortalama Yaş

Deneyimli Yönetim: UNHCL 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.2 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Andrew Witty	CEO & Non-Independent Director	4.3yrs	US$26.34m	0.012% CLP 39.8b
Stephen Hemsley	Non-Independent Non-Executive Chairman	25.3yrs	US$856.22k	0.14% CLP 445.6b
Michele Hooper	Lead Independent Director	17.6yrs	US$441.35k	0.00037% CLP 1.2b
Paul Garcia	Independent Director	3.5yrs	US$366.57k	0.00035% CLP 1.1b
Timothy Flynn	Independent Director	8.3yrs	US$400.77k	0.00050% CLP 1.6b
Charles Baker	Independent Director	1.5yrs	US$366.07k	Veri yok
Frederick McNabb	Independent Director	7.3yrs	US$393.60k	0.0015% CLP 4.9b
John Noseworthy	Independent Director	6.3yrs	US$390.76k	Veri yok
Valerie C. Rice	Independent Director	7.8yrs	US$424.26k	0.000040% CLP 129.2m
Kristen Gil	Independent Director	2.4yrs	US$514.77k	0.000080% CLP 258.4m

6.8yrs

Ortalama Görev Süresi

68yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: UNHCL 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.8 yıldır).

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2025/05/13 00:02
Gün Sonu Hisse Fiyatı	2025/05/13 00:00
Kazançlar	2025/03/31
Yıllık Kazançlar	2024/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

UnitedHealth Group Incorporated 56 Bu analistlerden 23, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
David Toung	Argus Research Company
Hua Ha	Baird
Joshua Raskin	Barclays

UnitedHealth Group Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

UnitedHealth Group Incorporated, Annual General Meeting, Jun 02, 2025

Independent Director recently bought CL$515m worth of stock

UnitedHealth Promotes Tim Noel as CEO of the UnitedHealthcare Business

Independent Director recently bought CL$515m worth of stock

Executive VP & Chief People Officer recently sold CL$430m worth of stock

Executive VP & Chief People Officer recently sold CL$430m worth of stock

Recent updates

UnitedHealth Group Incorporated Provides Update on Earnings Guidance for the Fiscal Year 2025

UnitedHealth Group Incorporated, Annual General Meeting, Jun 02, 2025

First quarter 2025 earnings released: EPS: US$6.85 (vs US$1.53 loss in 1Q 2024)

UnitedHealth Group Incorporated Revises Earnings Guidance for the Year Ending December 31, 2025

UnitedHealth Group Incorporated to Report Q1, 2025 Results on Apr 17, 2025

Full year 2024 earnings released: EPS: US$15.64 (vs US$24.12 in FY 2023)

Fourth quarter dividend of US$2.10 announced

UnitedHealth Group Authorizes Payment of Quarterly Dividend, Payable on March 18, 2025

Independent Director recently bought CL$515m worth of stock

UnitedHealth Promotes Tim Noel as CEO of the UnitedHealthcare Business

Independent Director recently bought CL$515m worth of stock

New minor risk - Financial position

Full year 2024 earnings released: EPS: US$15.51 (vs US$24.12 in FY 2023)

New minor risk - Share price stability

UnitedHealth Group Incorporated to Report Q4, 2024 Results on Jan 16, 2025

Executive VP & Chief People Officer recently sold CL$430m worth of stock

Executive VP & Chief People Officer recently sold CL$430m worth of stock

Third quarter dividend of US$2.10 announced

UnitedHealth Group Authorizes Payment of Quarterly Dividend, Payable on December 17, 2024

Third quarter 2024 earnings released: EPS: US$6.51 (vs US$6.31 in 3Q 2023)

UnitedHealth Group Incorporated Provides Earnings Guidance for the Full Year 2024

UnitedHealth Group Incorporated to Report Q3, 2024 Results on Oct 15, 2024

Upcoming dividend of US$2.10 per share

Second quarter dividend of US$2.10 announced

UnitedHealth Group Authorizes Payment of Quarterly Dividend, Payable on September 24, 2024

Senior VP & Chief Accounting Officer recently sold CL$1.5b worth of stock

Second quarter 2024 earnings released: EPS: US$4.54 (vs US$5.89 in 2Q 2023)

UnitedHealth Group Incorporated to Report Q2, 2024 Results on Jul 16, 2024

First quarter dividend of US$2.10 announced

UnitedHealth Group Announces Cash Dividend, Payable on June 25, 2024

UnitedHealth Group Incorporated Announces Management Changes, Effective June 4, 2024

First quarter 2024 earnings released: US$1.53 loss per share (vs US$6.01 profit in 1Q 2023)

UnitedHealth Group Incorporated, Annual General Meeting, Jun 03, 2024

First quarter 2024 earnings released: US$1.53 loss per share (vs US$6.01 profit in 1Q 2023)

UnitedHealth Group Incorporated Provides Earnings Guidance for the Full Year 2024

UnitedHealth Group Incorporated to Report Q1, 2024 Results on Apr 16, 2024

Court Substantially Denies United Healthcare’s Motion for Summary Judgment in ERISA Class Action: Case Moves to Trial

Executive VP & Chief People Officer recently sold CL$573m worth of stock

Fourth quarter dividend of US$1.88 announced

Full year 2023 earnings released: EPS: US$24.12 (vs US$21.47 in FY 2022)

Senior VP & Chief Accounting Officer recently sold CL$443m worth of stock

UnitedHealth Group Announces Quarterly Dividend, Payable on March 19, 2024

Executive VP & CEO of UnitedHealthcare recently sold CL$12b worth of stock

Unitedhealth Group Incorporated Announces Retirement of Dirk McMahon as President and Chief Operating Officer, Effective April 1, 2024

Full year 2023 earnings released: EPS: US$23.86 (vs US$21.47 in FY 2022)

UnitedHealth Group Incorporated to Report Q4, 2023 Results on Jan 12, 2024

Unitedhealth Group Incorporated Provides Earnings Guidance for the Year 2023 and 2024

Upcoming dividend of US$1.88 per share at 1.4% yield

Investor sentiment improves as stock rises 26%

UnitedHealth Group Incorporated Announces Cash Dividend, Payable on December 12, 2023

UnitedHealth Group Incorporated Appoints Charlie Baker to Board of Directors

Unitedhealth Group Incorporated Announces Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings released: EPS: US$6.24 (vs US$5.63 in 3Q 2022)

UnitedHealth Group Incorporated to Report Q3, 2023 Results on Oct 13, 2023

Upcoming dividend of US$1.88 per share at 1.6% yield

Unitedhealth Group Board Authorizes Payment of Quarterly Dividend, Payable on September 19, 2023

New major risk - Share price stability

CEO & Non-Independent Director recently sold CL$1.6b worth of stock

UnitedHealth Group Incorporated Provides Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings released: EPS: US$5.82 (vs US$5.41 in 2Q 2022)

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 24%

UnitedHealth Group Incorporated to Report Q2, 2023 Results on Jul 14, 2023

Unitedhealth Group Incorporated Announces Quarterly Cash Dividend, Payable on June 27, 2023

Mercy Investment Files an Exempt Solicitation and Urge Vote For its Proposal

Executive VP & Chief People Office recently sold CL$1.1b worth of stock

First quarter 2023 earnings released: EPS: US$5.95 (vs US$5.34 in 1Q 2022)

CEO Tazminat Analizi

CEO